Robinson James George 4
4 · NYMOX PHARMACEUTICAL CORP · Filed Apr 27, 2021
Insider Transaction Report
Form 4
Robinson James George
Director
Transactions
- Purchase
Common Stock
2021-04-22$2.10/sh+3,100$6,526→ 3,535,550 total - Purchase
Common Stock
2021-04-21$2.08/sh+900$1,870→ 3,523,550 total - Purchase
Common Stock
2021-04-22$2.07/sh+7,000$14,489→ 3,530,550 total - Purchase
Common Stock
2021-04-22$2.05/sh+5,000$10,250→ 3,540,550 total - Purchase
Common Stock
2021-04-22$2.08/sh+51$106→ 3,545,550 total - Purchase
Common Stock
2021-04-22$2.10/sh+800$1,680→ 3,546,350 total - Purchase
Common Stock
2021-04-21$2.09/sh+2,000$4,180→ 3,512,550 total - Purchase
Common Stock
2021-04-21$2.08/sh+6,000$12,480→ 3,518,550 total - Purchase
Common Stock
2021-04-22$2.13/sh+1,900$4,047→ 3,532,450 total - Purchase
Common Stock
2021-04-22$2.09/sh+2,900$6,061→ 3,549,250 total - Purchase
Common Stock
2021-04-22$2.09/sh+1,100$2,297→ 3,550,350 total - Purchase
Common Stock
2021-04-21$2.08/sh+4,100$8,528→ 3,522,650 total - Purchase
Common Stock
2021-04-22$2.09/sh+4,949$10,343→ 3,545,499 total - Purchase
Common Stock
2021-04-22$2.08/sh+200$417→ 3,550,550 total